bivalent分子を用いた変異型p53とRUNX1の結合による創薬

• Project/Area Number: 25KJ0961
• Research Category: Grant-in-Aid for JSPS Fellows
• Allocation Type: Multi-year Fund
• Section: 国内
• Review Section: Basic Section 50020:Tumor diagnostics and therapeutics-related
• Research Institution: The University of Tokyo
• Principal Investigator: 須崎 賢 東京大学, 医学系研究科, 特別研究員(DC2)
• Project Period (FY): 2025-04-22 – 2027-03-31
• Project Status: Adopted (Fiscal Year 2025)
• Budget Amount: ¥1,400,000 (Direct Cost: ¥1,400,000); Fiscal Year 2026: ¥800,000 (Direct Cost: ¥800,000); Fiscal Year 2025: ¥600,000 (Direct Cost: ¥600,000)